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Abstract 
Objective. To evaluate subchondral bone trabecular integrity (BTI) from a radiograph as a 
predictor of knee osteoarthritis (OA) progression. 
Methods. Longitudinal (baseline, 12- and 24-month) knee radiographs were available from 60 
female subjects with knee OA. OA progression was defined by 12- and 24-month change in 
medial compartment minimal joint space width (JSW), joint space area (JSA), and medial tibial 
and femoral cartilage volume from magnetic resonance imaging. Bone Trabecular Integrity (BTI) 
of the medial tibial plateau was analyzed by fractal signature analysis with a commercially 
available software tool. Receiver Operating Characteristic curves of BTI were used to predict 
5% change in OA progression parameters. 
Results. Individual terms (linear and quadratic) of baseline BTI of vertical trabeculae predicted 
knee OA progression based on 12- and 24-month change in JSA (p<0.01 for 24 months), 24-
month change in tibial (p<0.05) but not femoral cartilage volume, and 24-month change in JSW 
(p=0.05). ROC utilizing both terms of baseline BTI predicted 5% change in the OA progression 
parameters over 24 months with high accuracy as reflected by the area under the curve (AUC) 
measures: JSW 81%, JSA 85%, tibial 75% and femoral 85% cartilage volume. Change in BTI 
was also significantly associated (p<0.05) with concurrent change in JSA over 12 and 24 
months and change in tibial cartilage volume over 24 months.  
Conclusions. BTI predicts structural OA progression as determined by radiographic and MRI 
outcomes. BTI may therefore be worthy of study as an outcome measure for OA studies and 
clinical trials. 
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Introduction 
 The subchondral bone is thought to play a key role in the pathogenesis of osteoarthritis 
(OA) (1, 2). Subchondral bone changes in OA are potentially both a result and a cause of 
cartilage loss (3). The intimate relationship and conjoined disease pathways of both these 
pathological processes are demonstrated in several ways. First, recent data support the view 
that cartilage and bone can communicate over the calcified tissue barrier (4-6). Second, 
structural changes in subchondral trabecular bone are associated with cartilage loss in animal 
models of OA (7-9) and in human OA (3, 10, 11). Third, attenuating the expression of Dkk-1, a 
Wnt inhibitor that mediates remodeling of various tissue types, promotes chondrocyte survival 
and protects against both cartilage degradation and loss of subchondral bone mineral density 
(12).  
 Efforts to quantify trabecular bone structural changes in patients have included 
computed tomography (13, 14), magnetic resonance imaging (MRI) (3, 15, 16), and radiography 
(17-19). One approach for assessing trabecular integrity from radiographs uses fractal signature 
analysis that provides an indication of the number, spacing, and cross-connectivity of bone 
trabeculae (20). In a cohort with symptomatic knee OA, we recently showed that the baseline 
bone trabecular integrity (BTI) of the medial tibial plateau predicted medial knee joint space 
narrowing over the ensuing three years with 75% accuracy (based on ROC curve analysis) (19); 
whereas, in the same cohort, baseline joint space width was no more effective than random 
variables for predicting structural OA progression (19). With the exception of knee alignment, 
meniscal pathology, bone marrow lesions (21, 22), and frequent knee pain (23), to date there 
have been few other parameters with any significant ability to reliably predict knee OA 
progression in unselected OA populations, including traditional OA risk factors (age, gender and 
body mass index) (24, 25).  
 Clinical trials recruiting progressors on the basis of traditional OA risk factors suffer from 
containing only a minority (<30%) of knee OA progressors (26). More robust means of 
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identifying individuals at risk for OA progression over 1-3 years would be very valuable. Applied 
to a clinical trial testing the efficacy a potential structure modifying agent, such a method could 
enrich the trial with OA progressor subjects; this in turn could potentially lower trial costs due to 
the ability to maintain or boost study power with fewer subjects and/or the potential to shorten 
the trial duration.  
The goal of this study was to validate, in a second independent cohort, the predictive 
capability of BTI (measured by fractal signature analysis) for radiographic OA progression. We 
also evaluated BTI as a predictor of OA progression based on quantitative measures of articular 
cartilage loss obtained from magnetic resonance (MR) imaging. Finally, we evaluated change in 
BTI with concurrent change in OA progression parameters based on radiographic and MR of 
structural disease progression.  
 
Methods 
Patients 
Included in these analyses were all subjects (n=60) with radiographic knee OA from 6 clinical 
study sites that participated in the Pfizer A9001140 observational study (27). Included subjects 
were aged 40 years, female, had knee radiographs for at least two of three timepoints 
(baseline, and 12 and/or 24 months), frequent symptoms in the signal knee, mild to moderate 
radiographic OA in the medial femoro-tibial compartment of the signal knee (Kellgren Lawrence 
grades 2 to 3) (28), a body mass index (BMI) ≥ 30 kg/m2, and a medial tibiofemoral joint space 
width at baseline of > 2 mm in a posteroanterior modified Lyon-Schuss view. For patients with 
bilateral qualifying knees, the more symptomatic knee was selected to be the signal knee. 
Participants were excluded on the basis of a history of intra-articular fracture, arthroplasty, 
meniscectomy, crystal-associated arthropathy, knee infection, or avascular necrosis. While 
anterior cruciate ligament (ACL) tears were not part of the exclusion criteria, a review of medical 
histories revealed no cases of ACL injury and/or reconstruction. Details regarding the 
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medications permitted during the study were described previously (27). The study was 
conducted in compliance with the ethical principles derived from the Declaration of Helsinki and 
in compliance with the local Institutional Review Boards of the investigative sites, informed 
consent regulations, and International Conference on Harmonization of Good Clinical Practices 
Guidelines.   
 
Radiographic Imaging  
To evaluate radiographic OA progression it was important to rely on optimized knee radiographs 
to assure the validity of the joint space width (JSW) measurements. The Pfizer A9001140 study, 
utilized posteroanterior modified Lyon Schuss knee radiographs obtained with the SynaFlexerTM 
lower limb positioning frame (Synarc, San Francisco) (29) with a variable caudal X-ray beam 
angle chosen to minimize the tibial intermargin distance (the vertical distance between the 
anterior and posterior tibial margins at the center of the medial tibial plateau in the 2-D 
radiographic image) (30); this enabled extraction of reliable (accurate) quantitative JSW data for 
this study. Images were acquired digitally. The mean (SD) resolution was 138 (33) microns/pixel 
for radiographs from 6 of the clinical sites, but 300 (9) microns/pixel for one clinical site (only 
fluoroscopic images obtained, n=15 subjects); because these images provided only half the 
data points from which to construct FSA curves they were excluded for the purposes of these 
analyses. When necessary, more than one knee radiograph was performed for an individual, 
each with a different X-ray beam angle, to optimize (i.e. minimize) the intermargin distance. In 
these instances, the images with the smallest intermargin distances were chosen for BTI 
analysis. Overall, 176 images were available for analysis: 60 (baseline) + 58 (12 month) + 58 
(24 month).  
 
Image Analysis with the Optasia Knee Analyzer 
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All radiographs were analyzed using the KneeAnalyzer application developed by Optasia 
Medical (Manchester, UK). The KneeAnalyzer utilizes computer-aided detection based on 
statistical contour modeling to provide highly reproducible quantitative measurements of the 
medial compartment of the knee. Analysis of medial compartment BTI was performed as 
previously described (19). In addition, the software tool provided automated measurements of 
the medial minimum JSW in mm and the medial joint space area (JSA) in mm2. Both of these 
radiographic indices of knee OA progression were evaluated in this study. Joint space area 
represents the joint space width integrated over the majority of the medial compartment. The 
inner and outer JSA boundaries for this automated measurement were defined by the position 
of the inner and outer margins of the tibial fossa, as determined by the model-fitting process. 
The two landmarks defining these margins were as follows: the inner margin of the tibial fossa 
was the point where the lower margin of the tibial fossa (bowl) converged with the projected 
edge of the tibial plateau, on the side nearest to the inner edge of the knee; the outer margin of 
the tibial fossa was the point where the lower margin of the tibial fossa converged with the 
projected edge of the tibial plateau, on the side nearest to the outer edge of the knee (Figure 1). 
The two points are anatomical landmarks which have been marked consistently in a training set 
of example images and are located by the model-based segmentation using an active shape 
modeling algorithm for finding the whole tibial plateau. The mean landmark positioning error for 
the modeling algorithm is 2.1% of the tibial width (unpublished data). Although the 
KneeAnalyzer tool allows the user to edit the positions of the inner and outer joint space area 
boundaries, except in two instances, this was assiduously avoided to optimize reproducibility of 
the measure. In these two instances (one involving the medial boundary and one involving the 
lateral boundary), the boundary was manually repositioned immediately adjacent to the original 
boundary to ensure correct identification of minimal joint space location.  
The interrater reliability for medial JSW measurements was assessed by intra-class 
correlation coefficient (ICC) testing for concordance of measurements by the KneeAnalyzer 
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software tool with measurements made independently by a semi-automated method as reported 
previously (31). The ICC for JSW was 0.926; the ICC for JSA was 0.992 (based on analysis of 
245 radiographs from the PfizerA9001140 study by 4 analysts). The interrater reliability of BTI is 
very high as previously reported (19). 
 
Magnetic resonance imaging and extraction of medial compartment cartilage volume data   
MR imaging was performed on 3.0T Trio (Siemens AG, Erlangen, Germany) and Signa 
Excite/Genesis Signa MRI scanners (GE Healthcare Technologies, Waukesha, WI) as 
previously described (27, 31, 32). Transmit Receive Birdcage CP coils (Clinical MR Solutions 
Brookfield, WI) with a 'split top' design were used at all clinical study sites. Double oblique 
spoiled gradient recalled acquisitions (33) at steady state (SPGR) with selective water excitation 
were acquired at a spatial resolution of 1 mm (slice thickness) x 0.3125 mm x 0.3125 mm (in 
plane resolution), which were previously cross-calibrated (34). Other technical details for the 
acquisition were reported previously (27, 31). Overall, data from 161 images were available for 
analysis: 56 (baseline) + 54 (12 months) + 51 (24 months).  
 All MR data were sent to the Duke Image Analysis Laboratory for quality control and 
then shipped to the image analysis center (Chondrometrics GmbH, Ainring, Germany) where 
images were processed using custom software (27, 31, 33). The image segmentation was 
performed by seven operators with formal training and >3 years experience in cartilage 
segmentation. The images were processed as pairs (baseline and follow-up), but with blinding 
to the order of acquisition; i.e. when the partner data set (baseline or follow up) was segmented, 
the previously segmented one was uploaded and displayed on the screen. Quality control of all 
segmentations was performed by an expert (F.E.), who reviewed all segmented slices of each 
data set (33). The segmentations were used to compute the articular cartilage volume (VC) of 
the medial tibia (VC_MT), and the medial femur (VC_MF); these measures have been shown 
previously to be able to measured with high precision (33). 
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Definition of OA Progression 
For each structural parameter (two radiographic and two MRI), OA progression was defined as 
the difference between baseline and follow-up (12 or 24 months) value as follows: 1) the change 
in radiographic medial minimum JSW (JSW) and medial JSA (JSA); and 2) the change in 
cartilage volume of the medial tibia (VC_MT) and the medial femoral condyle (VC_MF). The 
mean (SD) 24-month change scores and standardized response means (SRMs) were 
calculated for each outcome.  
 
Statistical Analysis 
The analyses performed are consistent with those previously described in our development 
study (19). Briefly, sets of trabecular texture measurements (fractal dimensions) at a range of 
scales in the vertical and horizontal directions were modeled with second order (quadratic) 
multiple regression models using a non-centered polynomial. Hence, the multi-dimensional 
correlations between fractal dimension measures at these different scales were summarized by 
2 polynomial terms, which describe the functional “shape” of the way that trabecular texture 
signals depend on scale. It is these shape terms that constitute a bone trabecular integrity or 
BTI measurement. Clinical study site was included in the same statistical model with an analysis 
of co-variances (ANCOVA) framework and repeated measures. Age was not included because 
age, as shown previously (19), had no effect on BTI as a predictor of progression in the current 
analyses.  Statistical models examined the association of baseline BTI and knee OA 
progression at 12 and 24 months. We also assessed for concurrent change over 24 months in 
vertical BTI and OA progression measures. 
 The SRMs for change over 24 months were calculated for the knee OA progression 
variables by dividing the mean change by the standard deviation of the change scores. Receiver 
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Operating Characteristic (ROC) curves were used to quantify the accuracy of the prediction of 
the change in the OA progression variables by baseline BTI. The continuous 24-month change 
scores were recoded as binary variables where 1 equaled >5% decrease from the baseline 
value versus 0 (not meeting this criterion). ROC curves were constructed to predict change in 
medial JSA, medial JSW, VC_MT and VC_MF using 5-fold cross-validation with 300 replications 
(35). The prediction used the linear and quadratic BTI terms of the vertical trabeculae. 
 
Results 
Patients 
A total of 60 OA knees had available knee radiographs from at least two timepoints, baseline, 
and 12- and/or 24-month follow-up. Of these, 35% were KLG3 at baseline. The subjects had a 
mean (SD) age of 58 ± 8.5 years, and a mean (SD) BMI of 35.6 ± 5.5 kg/m2.  
 
Frequency of OA progression  
The SRMs were modest (Table 1), ranging from to -0.15 to -0.45. JSW correlated with JSA 
(R=0.62, p<0.0001), VC_MT (R=0.39, p=0.008), and VC_MF (R=0.29, p=0.049). A 5% 
decline in these variables was chosen as a threshold of progression as it provided a reasonable 
number of progressor subjects for Receiver Operator Characteristic curve analysis. A total of 
28-38% of the cohort was defined as progressors based on achieving a > 5% decline in the 
outcome variables over two years, yielding the following numbers of OA progressors for each 
outcome: 17 for JSA, 21 for JSW, 18 for VC_MT, and 23 for VC_MF.  
 
Baseline bone trabecular integrity predicted OA progression based on radiographic and MRI 
measures  
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To evaluate BTI of the medial tibial subchondral bone as a predictor of medial compartment 
knee OA progression, both the linear and quadratic BTI terms for the vertical and horizontal 
directions (vertical and horizontal trabeculae) were assessed in separate models. The BTI terms 
of the vertical trabeculae provided the only significant results in this cohort (Table 2). Both 
individual terms of baseline vertical BTI were associated with knee OA progression defined by 
change in JSA over 12 and 24 months, and VC_MT over 24 months. The quadratic term of 
baseline vertical BTI was also associated with JSW over 24 months at the p=0.05 level of 
significance but not VC_MF. These results were unchanged when controlled for baseline OA 
severity of each measure (data not shown). These findings confirm our prior results 
demonstrating that medial tibial BTI is a predictor of radiographic OA progression of the medial 
compartment of the OA knee. These results further expand our prior analysis, showing 
prediction of an MR based OA progression parameter by BTI. In contrast, baseline severity of 
OA did not predict progression as neither baseline JSW (p=0.88), nor baseline JSA (p=0.43), 
were associated with JSW over 24 months. 
   
Receiver Operating Characteristic Curves (ROC) for predicting OA progression 
To gain an appreciation of how BTI might benefit clinical trial design, we used ROC curves to 
evaluate the ability of baseline BTI to predict a 5% change over 24 months in the OA 
progression measures. This analysis used both of the BTI terms (linear and quadratic) for the 
vertical trabeculae as these proved to be the most highly associated with OA progression. To 
gain a realistic non-inflated appreciation of the predictive capabilities of BTI in this relatively 
small sample set, ROC curves were generated by cross-validation; curves were based on 
leaving out 20% of the data and regenerating the curves 300 times, i.e. 4-fold predicting 1-fold 
of the data iteratively). The highest area under the curve (AUC) and confidence intervals 
(corresponding to one standard deviation) were achieved for BTI prediction of 5% change in 
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JSA over 24 months (AUC 0.85, CIs 0.82-0.95) (Table 2). These results demonstrate that BTI 
is a significant and relatively strong predictor of OA progression. ROCs were also performed for 
BTI prediction of 5% change over 24 months in the other OA progression outcomes; this 
analysis yielded the following AUC results: 0.81 for JSW, 0.85 for VC_MF, and 0.75 for 
VC_MT (see Table 2 for 95% CIs). The ROC curves for each progression outcome (and 
curves corresponding to + one standard deviations) are shown in Figures 2A-D.  
 
Bone trabecular integrity changed concurrently with measures of OA progression 
Change in BTI was also associated with concurrent change in both radiographic and MR 
determined knee OA progression (Table 3). Specifically, the change in BTI of the vertical 
trabeculae was associated with JSA over 12 and 24 months and with VC_MT over 24 
months. Overall the strongest association was between BTI (linear term of the vertical 
trabeculae) and JSA (0.016). These results were unchanged when controlled for baseline OA 
severity of each measure (data not shown).   
 
Discussion 
 To our knowledge, this is the first demonstration that baseline BTI predicts OA 
progression based both on radiographic and MRI outcome measures. Although this study is 
smaller (60 versus 138 OA subjects) and of shorter duration (2 instead of 3 years) than our 
previous study (19), it confirms that baseline BTI predicted radiographic knee OA progression. 
Whether BTI was used to predict change in semi-quantitative joint space narrowing (AUC 0.75 
from prior work (19)) or the continuous JSW variable (AUC 0.81 in this study of a different 
cohort), the strength of the prediction was comparable. This is a valuable advance because 
continuous JSW is the FDA approved outcome measure for clinical trials of disease modifying 
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agents. This study extends our original results by demonstrating that baseline BTI also 
predicted JSA and cartilage volume loss by MRI. BTI was 85% predictive of ∆JSA when 28% 
of the cohort was defined as progressors based on a 5% ∆JSA for purposes of ROC analysis. 
We have not found baseline JSW to be a good predictor of progression in either this study (of 
non-stratified subjects) or in our previous study (19); however, JSN has been predictive of MRI 
progression in select OA patient subsets with more severe baseline JSN (36), or cartilage 
thinning when using a different progressor classification based on subregional cartilage changes 
in comparison to those in a healthy reference cohort (37). The overall predictive capability of BTI 
for OA progression suggests that BTI could be used to enrich an OA clinical trial with individuals 
likely to progress in the intermediate future (1-3 years). Other measures of trabecular texture 
from radiographs have been reported using dissimilarity measures; these have been used to 
classify OA status (38) and predict OA progression (39). The AUCs for predicting medial JSN in 
the latter study are comparable to our own based on BTI (AUC 0.77), adding further support for 
bone structure as a means of predicting OA progression. Another recent approach using WND-
CHARM (40) has been used to classify OA progressors, but the method relies on analysis of 
much of the gross morphology of the knee including the joint width in addition to the texture of 
the trabecular structure and is sensitive to imaging conditions, such as magnification and 
rotation. 
 Goldring has stated that the differential adaptive capacity of bone, compared with 
cartilage, likely underlies the more rapid appearance of detectable skeletal changes in bone in 
OA (41). We believe that this differential adaptive capacity explains the ability of BTI to predict 
subsequent loss of JSW, JSA, and cartilage volume: In other words, BTI acts as the "canary in 
the OA mine", changing more rapidly in response to adverse loading and events than cartilage 
and therefore predictive of subsequent radiographic JSW/JSA as well as MR determined OA 
progression. These results are consistent with a concept of BTI as an early indicator of a 
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change in the biomechanical environment of the knee that leads to cartilage loss and disease 
progression. 
 Day et al demonstrated that the volume fraction of trabecular bone was increased in OA, 
but surprisingly, that the bone elastic tissue modulus was reduced (42, 43). They attributed the 
reduction in bone elastic tissue modulus to a decrease in bone mineral density secondary to an 
increased rate of bone remodeling and incomplete bone mineralization. Ding also noted that 
severe OA is characterized by a higher than normal bone volume fraction, an abnormal low 
bone mineralization pattern, and lower mechanical strength (44). As summarized by Martel-
Pelletier, OA subchondral bone demonstrates an increased osteoid collagen matrix and an 
abnormal mineralization pattern resulting in hypomineralization of this tissue (1). Cox et al 
showed that subchondral bone volume fraction correlated strongly with a decrease in bone 
mineralization; furthermore they showed that these changes were related to local cartilage 
degeneration (45). Finally, Bailey et al have estimated that subchondral bone collagen of the OA 
femoral head possessed a 20-fold increase in bone turnover and a 25% decrease in 
mineralization (46). Taken together, these results are all consistent with a bone mineralization 
lag in the face of increased bone remodeling in knee OA progression. As in our prior study, in 
association with progression we observed decreased fractal dimensions in horizontal trabeculae 
compatible with an increase in their thickness, and increased fractal dimensions in vertical 
trabeculae compatible with an increase in the fenestration and thinning of vertical trabecular 
structures. The most appropriate interpretation, in light of the recent studies described above, is 
that BTI reflects an apparent thinning of vertical trabeculae on radiographs due to their 
undermineralization as a result of stress shielding and a high bone turnover state in OA 
progressors.  
 The meniscus (position and degeneration) has been shown to account for a substantial 
proportion (50%) of the variability in both JSA and JSW change (47). Subchondral bone 
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changes could also be an early consequence of meniscal extrusion and reflect the 
biomechanical changes resulting from meniscal extrusion (48). In this regard, it is interesting 
that BTI was more sensitive for predicting change in medial JSA than change in medial 
minimum JSW. JSA, a location specific computer measure, is potentially more sensitive than 
minimum JSW to progressive cartilage loss because it reflects an integral width measurement 
around the load-bearing region of the medial compartment; therefore, JSA would be expected to 
reflect meniscal degeneration and extrusion as well as articular cartilage loss. It is therefore 
logical to expect that BTI, a measurement across the span of the medial tibial subchondral 
bone, would be a better predictor of the loss of JSA, as shown here, than of narrowing of an 
isolated site represented by change in minimum JSW. Given that the interrater reliability and 
standardized response mean for JSA were high, it would seem worthy of study in other cohorts 
to further evaluate its sensitivity to change as a radiographic outcome measure for OA and OA 
clinical trials. 
An ideal screening test for progressive OA should be inexpensive, minimally 
burdensome for the patient, readily available at multiple centers, have high positive predictive 
value for detecting rapid progression, and a low screen failure rate (21). BTI is inexpensive, 
minimally burdensome as it is acquired from a plain knee radiograph, potentially readily 
available at multiple centers due to the commercial availability of the KneeAnalyzer software 
that generates the FSA data from which BTI terms can be extracted, and has high positive 
predictive value for detecting rapid progression; however, further work is needed in a larger 
prospective longitudinal trial to evaluate thresholds of BTI and their associated predictive value 
and screen failure rates. Moreover, BTI is minimally impacted by factors such as varying 
radiographic exposure, pixel size, and knee positioning (19, 49). The use of flat structuring 
elements instead of the usual spheres in the morphological image analysis used to extract 
texture, means that BTI is independent of linear changes in image intensity values. Although 
Lynch et al used macroradiographs rather than the standard radiographs used here, they 
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showed very good stability of the method to a wide range of magnifications (x1.0 - x2.0) (50). 
Cadaveric studies of the effect of knee positioning also demonstrated good stability of the 
method with a reproducibility of better than 2% CoV (49). In this regard BTI is superior to serial 
JSW determinations that require stringent control of knee positioning during imaging.  
Although BTI terms of the vertical trabeculae were the stronger predictor, our previous 
work also demonstrated prediction of OA progression by BTI terms of the horizontal trabeculae. 
In contrast to the previous study, the BTI terms of the horizontal trabeculae were not predictive 
of OA progression in this study; this may be due to the fact that our previous study included 
more subjects, a longer follow-up time, and categorical measures of radiographic OA 
progression rather than the subtler continuous measures of progression in this study. It was to 
be expected that BTI was a stronger predictor of OA progression over 24 months than 12 
months as this provided adequate time for measurable change in the joint parameters reflecting 
OA progression. BTI also changed concurrently with JSA and VC_MT. To date, three prior 
studies have evaluated concurrent change of subchondral medial tibial BTI and radiographic 
knee OA progression but results have been conflicting, with two positive (51, 52) and one 
negative (53) study. The results of this study corroborate the intimate relationship and conjoined 
disease pathways of both bone and cartilage pathology in OA, potentially mediated by the 
mechanical loading environment. 
A limitation of this study was the relatively small number of participants, which did not 
support multiple parallel testing between different cartilage metrics and implementations. 
Additionally only women were studied. A strength of the study was the use of high quality digital 
radiographs available through the Pfizer A9001140 study, providing radiographic outcomes of 
progression, as robust as is currently possible, and the availability of MR parameters of knee 
OA progression. This enabled us to evaluate the prognostic capability of BTI with the current OA 
clinical trial outcome, change in minimum JSW, as well as emerging outcomes, such as 
cartilage volume by MRI. The results with JSA in this study indicate it is worthy of additional 
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scrutiny, study and consideration as an outcome in OA trials. It is also attractive for being 
extractable from the same high quality knee OA radiographs as the currently accepted JSW 
standard for OA trials. We a priori tried to minimize manual selection of points in the joint 
profiles and found manual selection unnecessary—therefore, similar results should be readily 
obtainable by others using the commercially available KneeAnalyzer software.  
 In summary, BTI is a somewhat complicated but nevertheless a useful construct. This is 
the first study to show that baseline BTI can predict OA progression based on multiple 
measures including both radiographic and MR outcomes. Taken together with our prior study, 
we conclude that BTI can predict knee OA progression ensuing over a 12-36 month timespan, 
corresponding to the timespan of typical OA clinical trials. The fact that BTI changes 
concurrently with radiographic measures suggests that the pattern of BTI alterations is an 
integral feature of OA and OA progression. Finally, the BTI phenotype of OA progressors is 
compatible with apparent thinning of vertical trabeculae secondary to stress shielding and 
undermineralization due to high subchondral bone turnover. BTI could be a valuable adjunct in 
OA clinical trials for enriching a clinical trail with individuals at high risk for OA progression, 
thereby providing a means of increasing power and/or reducing study costs due to the need to 
enroll fewer trial participants.  
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Table 1. Joint structure characteristics at baseline and change over 24 months (including 
Standardized Response Means--SRMs) in imaging parameters of knee OA patients.  
 
 
JSA ΔJSA JSW ΔJSW VC_MT ΔVC_MT VC_MF ΔVC_MF 
Mean 104.25 -3.04 3.67 -0.20 12096.57 -62.8 6694.14 -14.9 
SD 19.57 10.02 0.95 0.74 3087.18 138.4 2003.35 100.4 
SRM NA -0.30 NA -0.27 NA -0.45 NA -0.15 
 
SD=standard deviation; SRM=standardized response mean; =change over 24 months; 
JSA=joint space area (in mm2); JSW=joint space width (in mm); VC_MT=cartilage volume of the 
medial tibia (in mm3); VC_MF=cartilage volume of the medial femoral condyle (in mm3); NA=not 
applicable; 
Cartilage volume parameter estimates are in mm3 (where the 3D coronal volume had voxel 
dimensions of 1.0 mm x 0.3125 mm x 0.3125 mm therefore 1 voxel = 0.09765625 mm3). 
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Table 2.  PREDICTION of osteoarthritis progression over 24 months by baseline medial 
tibial bone trabecular integrity (BTI).  
Trabecular 
Structure 
Direction 
OA 
Progression 
Outcome 
Baseline 
Linear BTI 
term 
Baseline 
Quadratic 
BTI term 
AUC 
(CIs for one standard 
deviation) for 
predicting 5% 
change over 24 
months in OA 
progression 
outcome 
  p values 
(parameter estimates)  
 
Vertical 
JSA* 
0.003 
(-59.6 
0.005 
(-191.9) 
0.85 (0.82, 0.95)  
JSW 
0.11 
(-2.4) 
0.05 
(-9.9) 
0.81 (0.79, 0.85)  
VC_MT 
0.015 
(-659.8) 
0.036 
(-1930.0) 
0.75 (0.71, 0.81)  
VC_MF 
0.24 
(-261.1) 
0.19 
(-994.5)  
0.85 (0.76, 0.86)  
Abbreviations listed in footer of Table 1.  
*Baseline BTI of vertical trabeculae was also significantly associated with JSA at 12 months: 
for linear BTI term p=0.007 (beta=-50.62), for quadratic BTI term p=0.011 (beta=-159.72); 
All models were adjusted for investigational site.  
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Table 3.  Association of CONCURRENT change in subchondral medial bone trabecular 
integrity (BTI) and osteoarthritis progression over 24 months.  
   
Trabecular 
Structure 
Direction 
OA Progression 
Outcome Linear BTI term 
Quadratic BTI 
term 
  p values  
(parameter estimates) 
Vertical 
JSA* 
0.016  
(-42.7) 
0.035  
(-116.3) 
JSW 
0.12  
(-2.0) 
0.17  
(-5.7) 
VC_MT 
0.027 
(-506.5) 
0.044 
(-1446.4) 
VC_MF 
0.07 
(-339.1) 
0.05 
(-116.9) 
Abbreviations listed in footer of Table 1. 
*The concurrent change in FSA of vertical trabeculae was also significantly associated with 
JSA over 12 months: for the linear BTI term p=0.007 (beta=-43.55), for the quadratic BTI term 
p=0.021 (beta=-116.94). 
The models were adjusted for investigational site. 
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Legends 
 
 
Figure 1. Landmarks used to quantify joint space area. The inner and outer joint 
space area boundaries were defined by the position of the inner and outer margins of 
the tibial fossa landmark respectively, as determined by the model-fitting process of the 
KneeAnalyzer tool. These two points (indicated by black asterisks) were defined as 
follows: the inner margin of tibial fossa was the point where the lower margin of the tibial 
fossa (bowl) converged with the projected edge of the tibial plateau, on the side nearest 
to the inner edge of the knee (point 35 in the annotated image); the outer margin of the 
tibial fossa: the point where the lower margin of the tibial fossa converges with the 
projected edge of the tibial plateau, on the side nearest to the outer edge of the knee 
(point 36 in the annotated image). These two points are located implicitly by the model-
based segmentation algorithm for finding the whole tibial plateau. 
 
Figure 2. Receiver Operating Characteristic (ROC) curve of bone trabecular 
integrity (BTI) for predicting osteoarthritis progression over 24 months. ROC 
curve analysis was performed to evaluate the capability of medial compartment 
subchondral tibial BTI to predict a 5% change over 24 months in: A) medial joint space 
area (JSA); B) medial minimum joint space width (JSW); C) medial tibial cartilage 
volume (VC_MT); and D) medial femoral cartilage volume (VC_MF). Curves depict the 
AUC (red line), plus (blue line) and minus (green line) one standard deviation (SD) 
derived after conservative iterative cross-validation. 
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